Targovax ASA (GB:0RIS) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Circio Holding ASA is expanding its share capital through a conversion of convertible bonds into over 4 million new shares, following a request by Atlas Special Opportunities. This move comes alongside a financing commitment from Atlas to support Circio’s operations until mid-2025. As the company focuses on advancing its innovative RNA therapeutics, including a promising cancer vaccine, this financial restructuring aims to bolster its ambitious research and development agenda.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
